Dr. Reddy's Laboratories Limited ( RDY) - Key Metrics
RDY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | ? | ? | ? | ? |
| 2026Q3 | $104.81 | $14.53 | $12.41 | $4.36 |
| 2026Q2 | $105.50 | $17.22 | $18.66 | $6.52 |
| 2026Q1 | $102.58 | $17.02 | $17.56 | $5.38 |
| 2024Q4 | $101.96 | $19.10 | $26.37 | $17.18 |
RDY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | ? | ? |
| 2026Q3 | ? | 21.88 |
| 2026Q2 | 46.33% | 17.77 |
| 2026Q1 | ? | 18.85 |
| 2024Q4 | ? | 15.08 |
RDY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 0.99% | ? |
| 2026Q3 | 0.34% | ? |
| 2026Q2 | 0.53% | 0.65% |
| 2026Q1 | 0.42% | ? |
| 2024Q4 | 1.14% | ? |
RDY
Price: $12.56
Dividend Yield: 0.64%
Forward Dividend Yield: 0.66%
Payout Ratio: 24.14%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.53 USD
P/E Ratio: 25.83
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: India
Volume: 129000
Ebitda: 142.4 millionMarket Capitalization: 12.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: -8.82%
DGR5: 30.00%
DGR10: 30.00%